Rob Stein
Stories
-
Health
CDC Director Walensky Overrules Advisers On Boosters For At-Risk Workers
Walensky made a recommendation that CDC advisers rejected — giving a third shot to at-risk workers such as those in the health care industry. Her decision sides with what the FDA recommended.
-
National
Is The Worst Over? Modelers Predict A Steady Decline In COVID Cases Through March
Though infections are still sky-high, the U.S. may be turning a corner, according to a consortium of researchers who forecast the pandemic. And we may well be spared a winter surge.
-
National
Johnson & Johnson Says Booster Shot Makes Their COVID Vaccine More Effective
With the FDA poised to authorize a Pfizer booster, a CDC advisory panel is scheduled to consider who exactly should get it. Johnson & Johnson says a booster also works for its one-shot vaccine.
-
Health
J&J Says Its Booster Shot Provides Increased Protection From COVID-19
Johnson & Johnson says a booster six months after the first shot increases antibodies 12-fold, indicating a second shot would provide added protection.
-
Health
Moderna Leads The Authorized COVID Vaccines In Lasting Effectiveness
But the researchers stressed that all three vaccines, including the Pfizer and Johnson & Johnson shots, provide strong protection against people getting so sick that they end up in the hospital.
-
Health
COVID-19 Stats: Deaths Are Up, Delta Variant May Be Starting To Wane
As the delta surge continues, there are signs it may be slowing in hard-hit states like Florida and Texas. But with fall coming, experts worry another surge could hit northern states.
-
Health
The White House Is Expected To Announce A 6-Prong Plan To Address The Pandemic
The Biden administration plans to unveil another strategy to fight the latest COVID-19 surge driven by the delta variant, after a series of setbacks and missteps in the battle against the pandemic.
-
Science
Johnson & Johnson Says A Booster Shot For Its Vaccine May Have Big Benefits
The company said that when study participants were given a second jab after six months, their antibody levels were nine times higher than they were 28 days after a first dose of the COVID-19 vaccine.
-
National
J&J Says A Booster Shot For Its Vaccine After 6 Months May Have Big Benefits
Johnson & Johnson said that when it gave study participants a second jab after six months, their antibody levels were nine times higher than they were 28 days after a first dose of the COVID vaccine.
-
Health
FDA Gives Full Approval To Pfizer's COVID-19 Vaccine
FDA gives full approval to Pfizer's COVID-19 vaccine, a highly anticipated move that could give the nation's vaccination campaign a badly needed boost.